ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 332186 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 332186; 2) Community: the network communities that were significantly associated with the response to NSC 332186; 3) Molecule: the relationships between components within communities and NSC 332186; 4) MDR: the compounds that were significantly associated with the NSC 332186.

NSC Compound Enrichment Correlation
NSC 742295 (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.00587884296262138 0.26282947
NSC 658798 Null 0.00623623671415521 0.19004419
NSC 707616 2,6-diamino-4-cyclohexylmethoxy-5-nitrosopyrimidine 0.00623623671415521 0.16431933
NSC 240419 Benzoic acid, 2-[[4-[bis(2-bromopropyl)amino]-2-methylphenyl]azo]- 0.00671035899671664 0.17118417
NSC 336003 Olivacinium acetate-NB methyl RB 544 0.00671035899671669 -0.26049803
NSC 38090 Null 0.00671035899671669 0.28279613
NSC 56902 Null 0.00671035899671669 0.014951373
NSC 682306 N-[p-[N-(2,4,7-triamino-6-pteriddinylmethyl)-N-methylamino]benzoyl]glutamic acid 0.00671035899671669 -0.043676727
NSC 683557 Camptothecin Derivative 0.00671035899671669 0.01908511
NSC 698281 Null 0.00671035899671669 0.34717284
Total:54  Current:7    [First] [Prev] [Next] [Last]